Printer Friendly

Catalent Applied Drug Delivery Institute To Host Symposium On Smart Drug Development And Design / News / News & Events.

M2 PRESSWIRE-September 26, 2019-: Catalent Applied Drug Delivery Institute To Host Symposium On Smart Drug Development And Design | News | News & Events



SOMERSET, N.J.- The Catalent Applied Drug Delivery Institute today announced that along with Columbia University's Lab-to-Market Accelerator Network and the Translational Therapeutics Accelerator (TRx), it will co-host a one-day symposium titled "Smart Drug Development & Design" at Columbia University, New York, on Wednesday, Oct. 2, 2019

The symposium will be chaired by Cornell Stamoran, Ph.D., Co-Chair of the Catalent Applied Drug Delivery Institute, and will feature Mike Rea, CEO, IDEA Pharma, Jim Spavins, former Head of Pfizer's Global PTx Pharmaceutical Sciences group, and a diverse group of industry leaders and researchers.

The first half of the symposium will help delegates understand the scientific concepts and technical know-how underpinning early preclinical studies. The second half of the day will transition the focus on strategies for successful drug products: patient-focused drug design; manufacturing; working with partners; and commercialization. The event will also give attendees the opportunity to apply what they have learned in an interactive audience participation session.

Registration and full details of the agenda can be found at .

Media Contacts

Chris Halling

+44 (0)7580 041073

Richard Kerns

+44 (0) 161 728 5880

Notes for Editors About Catalent Applied Drug Delivery Institute

Catalent's Applied Drug Delivery Institute was founded in 2012 to serve as a link between industry and academia, advance education and training in drug delivery in academia and the industry, accelerate adoption of applied drug delivery technologies to develop better treatments, and foster industry collaboration on major issues pertaining to drug development, formulation, and delivery. It is pursuing a multi-tiered approach of research, strategic counsel, and educational programs to advance the adoption of drug delivery technologies to improve patient outcomes.For more details on the Catalent Institute, visit and follow the Catalent Institute on Twitter: @DrugDeliveryIns About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs nearly 13,000 people, including approximately 2,400 scientists, at more than 35 facilities across five continents, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit More products. Better treatments. Reliably supplied.(TM)

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at on the world wide web. Inquiries to
COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Presswire
Date:Sep 26, 2019
Previous Article:Sherpa partners with the Conscious Advertising Network.
Next Article:Inflammation Amps Up Neurite Growth, Gene Expression Involved in Heat, Cold Sensitivity.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters